Investigation of dabigatran secretion into breast milk: Implications for oral thromboprophylaxis in post-partum women

Am J Hematol. 2020 Jan;95(1):E10-E13. doi: 10.1002/ajh.25652. Epub 2019 Oct 17.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antithrombins / pharmacokinetics
  • Dabigatran / pharmacokinetics*
  • Dabigatran / therapeutic use
  • Factor Xa Inhibitors / therapeutic use
  • Female
  • Fetal Blood / chemistry
  • Humans
  • Infant, Newborn
  • Milk, Human / chemistry*
  • Postpartum Period*
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / prevention & control*

Substances

  • Antithrombins
  • Factor Xa Inhibitors
  • Dabigatran